Global Human Immunodeficiency Virus (HIV) Diagnosis Market Growth Analysis 2024 – Forecast Market Size And Key Factors Driving Growth

Overview and Scope
Human immunodeficiency viruses (HIV) diagnosis refers to the process of determining whether an individual has been infected with the human immunodeficiency virus (HIV), the virus that causes acquired immunodeficiency syndrome. This diagnosis involves testing for the presence of HIV antibodies, antigens, or viral genetic material in a person's blood, saliva, or other bodily fluids.

Sizing and Forecast
The HIV diagnosis market size has grown rapidly in recent years. It will grow from $3.79 billion in 2023 to $4.2 billion in 2024 at a compound annual growth rate (CAGR) of 11%. The growth in the historic period can be attributed to expansion of voluntary counseling and testing, development of HIV antibody tests, emergence of the HIV/AIDS epidemic, and community-led and peer-led initiatives.

The HIV diagnosis market size is expected to see rapid growth in the next few years. It will grow to $6.42 billion in 2028 at a compound annual growth rate (CAGR) of 11.2%. The growth in the forecast period can be attributed to public health campaigns and awareness initiatives, focus on equity and inclusivity, routine testing in healthcare settings, community-led and peer-led approaches, and expansion of self-testing. Major trends in the forecast period include advancements in testing technologies, focus on targeted testing strategies, community-based testing and outreach, emphasis on equity and inclusivity, and policy and funding priorities.

Order your report now for swift delivery, visit the link:
https://www.thebusinessresearchcompany.com/report/human-immunodeficiency-virus-hiv-diagnosis-global-market-report 

Segmentation & Regional Insights
The human immunodeficiency virus (HIV) diagnosis market covered in this report is segmented –

1) By Product: Consumables, Instruments, Software And Services
2) By Mode: Self-Test, Lab-Based
3) By End User: Diagnostic Laboratories, Hospitals, Research Institutions

North America was the largest region in the HIV diagnosis market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human immunodeficiency virus (HIV) diagnosis market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15587&type=smp 

Major Driver Impacting Market Growth
The rising blood donation is expected to propel the growth of the HIV diagnosis market going forward. Blood donation refers to the voluntary act of giving blood through phlebotomy, where a needle is inserted into a vein to collect blood. The rise in blood donation combines advancements in medical technology, community engagement, and improved donor recruitment and retention strategies. With more people donating blood, a larger pool of samples is available for HIV testing. This increased availability of blood samples allows for more comprehensive screening for HIV antibodies or antigens, improving the accuracy and reliability of HIV diagnosis. For instance, NHS Blood and Transplant, a UK-based government agency, increased the number of new blood donors from 119,016 in 2022-2023 to 119,371 in 2023-2024. Therefore, rising blood donation is driving the growth of the HIV diagnosis market.

Key Industry Players
Major companies operating in the human immunodeficiency virus (HIV) diagnosis market are Thermo Fisher Scientific Inc., Abbott Laboratories, Siemens Healthineers, Roche Diagnostics , Becton Dickinson and Company, Hologic Inc., bioMérieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Bio-Techne Corporation, Alere Inc., Cepheid Inc. , OraSure Technologies Inc., Advanced Instruments Inc., BBI Solutions, Chembio Diagnostic Systems Inc., BioLytical Laboratories Inc., Avioq Inc., Advanced Biochemicals Ltd., Advanced Molecular Diagnostics, Atila BioSystems Inc., BioAssay Works LLC, Chemtron Biotech Inc.

The human immunodeficiency virus (hiv) diagnosis market report table of contents includes:

1. Executive Summary
2. Human Immunodeficiency Virus (HIV) Diagnosis Market Characteristics
3. Human Immunodeficiency Virus (HIV) Diagnosis Market Trends And Strategies
4. Human Immunodeficiency Virus (HIV) Diagnosis Market - Macro Economic Scenario
5. Global Human Immunodeficiency Virus (HIV) Diagnosis Market Size and Growth
.
.
.
32. Global Human Immunodeficiency Virus (HIV) Diagnosis Market Competitive Benchmarking
33. Global Human Immunodeficiency Virus (HIV) Diagnosis Market Competitive Dashboard
34. Key Mergers And Acquisitions In The Human Immunodeficiency Virus (HIV) Diagnosis Market
35. Human Immunodeficiency Virus (HIV) Diagnosis Market Future Outlook and Potential Analysis
36. Appendix

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info 

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company 
Twitter: https://twitter.com/tbrc_info 
Facebook: https://www.facebook.com/TheBusinessResearchCompany 
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ 
Blog: https://blog.tbrc.info/ 
Healthcare Blog: https://healthcareresearchreports.com/ 
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model